glp-1 intracranial hypertension use linked to fewer headaches in idiopathic neurologist discusses the role of
Description
However, directing GLP-1 drugs to this area alone to turn on those neurons did not cause weight loss
Am J Physiol Endocrinol Metab 296: E473E479
TL;DR GLP-1 microdosing involves taking significantly lower doses of medications like semaglutide (0.05-0.25mg weekly) compared to standard therapeutic doses (0.25-2.4mg)
As reported by CNBC, Notably, the survey also found that 40% of participants reported smoking traditional cigarettes at least weekly before starting a GLP-1, but that number declined to 24% after treatment
